LORBRENA vs SUTENT

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 19, 2026·How we rate

Possible drug interaction. LORBRENA and SUTENT are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	LORBRENA	SUTENT
Rating	64/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	LORLATINIB	SUNITINIB MALATE
Manufacturer	Pfizer	Cppi Cv
Dosage forms	Tablet	Capsule
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	Boxed warning
Treats	—	Renal Cell Carcinoma, Pancreatic Neoplasms, Neuroendocrine Tumors

lorbrena sutent

Rating

64/100

New

Pharmacy pays

—

Type

Active ingredient

LORLATINIB

SUNITINIB MALATE

Manufacturer

Pfizer

Cppi Cv

Dosage forms

Tablet

Capsule

Drug class

Kinase Inhibitor

Boxed warning

None

Boxed warning

Treats

—

Renal Cell Carcinoma, Pancreatic Neoplasms, Neuroendocrine Tumors

Frequently asked questions

What is the difference between Lorbrena and Sutent?

Lorbrena contains Lorlatinib, while Sutent contains Sunitinib Malate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.